Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05208047
Title (Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Cogent Biosciences, Inc.
Indications

gastrointestinal stromal tumor

Therapies

Sunitinib

PLX9486 + Sunitinib

PLX9486

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.